AGP Executive Report
Last update: an hour agoMedical Access in Czechia: SÚKL has issued a positive reimbursement decision for Er-Kim’s Vafseo® (vadadustat) for symptomatic anaemia in adult CKD patients on chronic dialysis, adding it to the national reimbursement list from 1 September 2026 and giving patients a once-daily oral option. Public Health Policy: The Czech government is tightening rules on kratom—raising the legal purchasing age, banning online sales, and cracking down on illegal sellers as part of a “war on the grey zone” ahead of planned entry into force in 2027. Infectious Disease Watch: WHO reports 11 African countries with active mpox transmission in six weeks (6 July–16 August 2026), with 1,153 confirmed cases and seven deaths; Madagascar leads with 785 cases, while WHO warns figures may be undercounted due to reporting delays. Cancer Prevention Reminder (Czech): A Prague radiation oncologist urges people to check less-obvious skin areas for suspicious moles and changes, including scalp, around ears, and the back/shoulders, stressing that skin damage can show up long after sun exposure. Clinical Research (Czech trial): A Czech multi-centre randomized study finds catheter-directed thrombolysis with alteplase plus anticoagulation lowers short-term risk in intermediate-to high-risk pulmonary embolism compared with anticoagulation alone. Safety & Care: A school bus crash in Germany injured 16 children (plus 24 unhurt), with hospitals treating them for “acoustic trauma” after a tyre burst and mass-casualty response.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.